Related Experiment Video
Updated: Aug 19, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Association of PiSlope with lung function decline in individuals with preserved spirometry: a prospective cohort
Suyin Huang1,2,3, Fan Wu1,3, Yuheng Wang4,3
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Diseases, National Center for Respiratory Medicine and Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Background:
Airway remodelling precedes airflow obstruction in COPD. Pi10 assumes a consistent fixed slope between airway wall thickness and lumen perimeter across individuals. PiSlope comprehensively quantifies airway wall thickening, which is associated with increased acute exacerbation and mortality risk. Whether PiSlope is associated with respiratory prognosis in participants with preserved spirometry is unknown.
Methods:
Participants with preserved spirometry with complete baseline questionnaires, spirometry and chest computed tomography were enrolled from a 3-year prospective Early Chronic Obstructive Pulmonary Disease (ECOPD) cohort study and divided into four groups by PiSlope quartile (Q) (Q1: PiSlope ≥0.4946, Q2: 0.4550≤ PiSlope <0.4946, Q3: 0.4149≤ PiSlope <0.4550, Q4: PiSlope <0.4149). Clinical outcomes included lung function decline and risk of airflow obstruction progression.
Results:
1140 participants with preserved spirometry were included and 1067 (93.6%) completed at least one follow-up lung function assessment. One standard deviation decrease in PiSlope was associated with accelerated decline in pre-bronchodilator forced expiratory volume in 1 s (FEV1) (adjusted difference 5 mL·year-1, 95% CI 1-9 mL·year-1; p=0.007) and post-bronchodilator FEV1 (adjusted difference 4 mL·year-1, 95% CI 0-9 mL·year-1; p=0.033), and increased airflow obstruction risk (unadjusted: OR 1.21, 95% CI 1.01-1.36, p =0.038; adjusted: OR 1.13, 95% CI 0.87-1.32, p=0.307). Q2-Q4 had accelerated decline in pre-bronchodilator FEV1 and FEV1 % predicted, compared with Q1 (all p<0.05). The third-year risk of airflow obstruction progression was higher in Q2 (adjusted OR 2.40, 95% CI 1.13-5.08; p=0.022), Q3 (adjusted OR 1.71, 95% CI 0.77-3.82; p=0.188) and Q4 (adjusted OR 2.04, 95% CI 0.92-4.53; p=0.078) than in Q1.
Conclusion:
Lower PiSlope was associated with faster lung function decline and increased airflow obstruction risk in participants with preserved spirometry, but the association between PiSlope and progression to airflow obstruction was not significant after adjustment.
Related Concept Videos
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Management Using Bronchodilators and Corticosteroids